Skip to main content
. 2018 Dec 18;4:116. doi: 10.1038/s41420-018-0133-7

Fig. 4.

Fig. 4

Effects of miRNA-125b-2-3p in HCT-116 and DLD-1 cells treated with 5-FU, oxaliplatin and CPT-11. The cells were treated with specific mimics and inhibitors, and the inhibition rates were measured by MTS assay after anticancer drug treatment for 72 h. Points, mean (n = 3); bars, SD